Skip to main content
. 2007 Jul 30;152(2):240–248. doi: 10.1038/sj.bjp.0707385

Figure 6.

Figure 6

(a) Somatostatin (SST) mobilization in response to local microinfusion of pituitary adenylate cyclase-activating peptide (PACAP; horizontal bar). Gastrin was without effect; n=5–8. (b) Histamine mobilization (integrated 3-h response) following microinfusion of gastrin or PACAP, PACAP with SST, PACAP with the SST receptor type 2 (SSTR2) antagonist PRL-2903 (PRL) i.v. (1.5 mg kg−1 bolus followed by 1.5 mg kg−1 h−1 for 3 h) or PACAP with SST and PRL; n=6–10. (c) Histamine mobilization in response to PACAP microinfusion (horizontal line) with or without the concomitant intravenous infusion of PRL; n=5, *P<0.05. In (a–c) means±s.e.means (vertical lines) are shown.